All In Biotech

Free tool

FAERS Monitor: Lupron Depot

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020708 or its brand name (Lupron Depot, Leuprolide Acetate). Reports on generic versions are filed under their own applications.

Reports

29,123

Serious

17,188

59% of reports

Hospitalization

6,639

Death reported

4,144

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • hot flush3,487
  • death2,333
  • fatigue1,923
  • headache1,462
  • pain1,285
  • drug ineffective1,187
  • nausea1,180
  • arthralgia1,082
  • asthenia998
  • abdominal pain942
  • off label use938
  • vaginal haemorrhage878
  • dizziness870
  • fall837
  • insomnia776

Reports by year received

View as table
YearReports
2004127
2005119
2006106
2007141
2008506
2009978
20101,324
20111,582
20121,181
20131,670
20142,641
20152,663
20161,865
20171,342
20181,384
20191,495
20201,350
20211,527
20221,854
20231,614
20241,500
20251,148
20261,006

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,025,036 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hot flushSignal3,48735.033.9110,159
vaginal haemorrhageSignal87814.913.911,155
abdominal painSignal9422.92.81,206
insomniaSignal7762.12.0455
death2,3332.01.91,137
asthenia9981.91.8445
arthralgia1,0821.91.8454
fall8371.81.7312
fatigue1,9231.81.7688
headache1,4621.71.6419
pain1,2851.51.4228
dizziness8701.31.248
nausea1,1801.11.07
off label use9380.80.765
drug ineffective1,1870.70.6238

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.